Prevention of bone loss with alendronate in postmenopausal women under 60 years of age.
Davis
L
L
D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*
D004164:Diphosphonates; D019386:Alendronate